hypoxanthine has been researched along with Embolism, Pulmonary in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Giordano, N; Hagan, K; Harrington, LB; Kabrhel, C; Kim, J; Kraft, P; Lasky-Su, JA; Lindstrom, S; Parry, BA; Poole, EM; Van Hylckama Vlieg, A; Zeleznik, OA | 1 |
1 other study(ies) available for hypoxanthine and Embolism, Pulmonary
Article | Year |
---|---|
Metabolomic analysis of 92 pulmonary embolism patients from a nested case-control study identifies metabolites associated with adverse clinical outcomes.
Topics: Adolescent; Adult; Aged; Carnitine; Case-Control Studies; Fatty Acids; Female; Hemoglobins; Humans; Hypoxanthine; Inosine; Male; Metabolome; Middle Aged; Porphyrins; Prospective Studies; Pulmonary Embolism; Purines; Risk Assessment; Treatment Outcome; Tricarboxylic Acids; Young Adult | 2018 |